1. Home
  2. LMNR vs HUMA Comparison

LMNR vs HUMA Comparison

Compare LMNR & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Limoneira Co

LMNR

Limoneira Co

HOLD

Current Price

$13.30

Market Cap

235.0M

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$0.71

Market Cap

191.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMNR
HUMA
Founded
1893
2004
Country
United States
United States
Employees
N/A
184
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
235.0M
191.4M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
LMNR
HUMA
Price
$13.30
$0.71
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
8
Target Price
$20.00
$6.19
AVG Volume (30 Days)
104.5K
18.7M
Earning Date
06-08-2026
05-15-2026
Dividend Yield
2.37%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$159,723,000.00
N/A
Revenue This Year
N/A
$444.16
Revenue Next Year
$13.95
$248.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.67
$0.55
52 Week High
$16.62
$2.84

Technical Indicators

Market Signals
Indicator
LMNR
HUMA
Relative Strength Index (RSI) 53.88 38.62
Support Level $12.54 $0.60
Resistance Level $13.65 $1.26
Average True Range (ATR) 0.39 0.10
MACD 0.01 -0.01
Stochastic Oscillator 58.13 31.40

Price Performance

Historical Comparison
LMNR
HUMA

About LMNR Limoneira Co

Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: